Wednesday 13th August 2008
0700 - 1800	Registration Desk Open
0715 - 0815	Early Morning Workshop 22 EMW22 Bayside Auditorium B	Early Morning Workshop 23 EMW23 Parkside Auditorium	Early Morning Workshop 24 EMW24 Bayside Auditorium A	Early Morning Workshop 25 EMW25 Bayside Room 102	Early Morning Workshop 26 EMW26 Parkside Ballroom B	Early Morning Workshop 27 EMW27 Parkside 110A	Early Morning Workshop 28 EMW28 Bayside Room 204 A & B	Early Morning Workshop 29 EMW29 Bayside Gallery	Early Morning Workshop 30 EMW30 Bayside Room 103	Early Morning Workshop 31 EMW31 Parkside 110 B	Early Morning Workshop 32 EMW32 Bayside Room 104
	ROTRF - Graft Rejection and Acceptance: Pathways to a New Clinical Era	Liver Allocation	BK Virus	Composite Tissue Transplants	Ethics - Organ Commerce and Trafficking in a Global Perspective	JDRF International - The Debate. Future Sources of Islets in Islet Transplantation	Laparoscopic Live Kidney Donation	KDIGO Guidelines for Kidney Transplant Recipients	Access to Transplantation by Indigenous Populations	Bone Disease after Kidney Transplantation	Protocol Biopsies of Kidney Transplant
	Chairs: Gerhard Opelz, Robert Colvin	Chairs: Geoffrey McCaughan, Sue McDiarmid	Chairs: Toby Coates, Parmjeet Randhawa	Chairs: Raimund Margreiter, Earl Owen	Chairs: Ian Kerridge, Jan J. van Busschbach	Chairs: Robert Goldstein, Philip O'Connell	Chairs: David Nicol, Andrew Ready	Chairs: Jonathan Craig, Martin Zeier	Chairs: Karen Yeates, Alan Cass	Chairs: Grahame Elder, John Eisman	Chairs: Brian Nankivell, Cinthia Drachenberg
0715	Cell-mediated Rejection: An Expanding Definition	Allocation in North America Based on Meld	Do We Need a Pathologist for Clinical Management?	Immunological Challenges of Hand Transplantation	Update on Global Organ Commerce and Trafficking	Opportunities for JDRFI Research Funding	Hand Assisted Laparoscopic Donor Nephrectomy	An Overview of KDIGO and the Transplant Guidelines	Indigenous Access in Australia, Canada, New Zealand and USA	Causes of Metabolic Bone Disease after Kidney and Kidney/Pancreas Transplantation	Role of Protocol Biopsies to Detect Subclinical Rejection
	Allan Kirk (Atlanta, USA)	Sue McDiarmid (Los Angeles, USA)	Parmjeet Randhawa (Pittsburgh, USA)	Stefan Schneeberger (Pittsburgh, USA)	Michael Bos (The Hague, The Netherlands)	Dorota Pawlak (Sydney, Australia)	Andrew Ready (Birmingham, UK)	Yves Vanrenterghem (Leuvem, Belgium)	Meg Jardine (Sydney, Australia)	Grahame Elder (Sydney, Australia)	Brian Nankivell (Sydney, Australia)
0730	Antibody-mediated Rejection: The Next Frontier	Allocation in Europe	Prevention is Better than Current Therapy	Functional Aspects of Hand Transplantation	The Recipient Perspective: Motives, Risks and Options for Potential Transplant Tourist	Stem Cells	Pure Laparoscopic Donor Nephrectomy	Immunosuppressive Medication Guidelines	They Really Want to Go Back Home - They Hate it Here	Management Options – Is There Evidence for Efficacy?	Protocol Biopsies and Chronic Allograft Damage: Why, When and Where?
	Philip Halloran (Edmonton, Canada)	David Mayer (Birmingham, UK)	William Bennett (Portland ,USA)	Christina Kaufman (Louisville, USA)	A. Vathsala (Singapore)	Scientific Debate by JDRFI Funded Researchers	Howard Lau (Sydney, Australia)	Henrik Ekberg (Lund, Sweden)	Karen Yeates (Kingston, Canada)	Carmel Hawley (Brisbane, Australia)	Daniel Serón (Barcelona, Spain)
0745	Identification of Operational Tolerance in Clinical Liver Transplantation	Allocation in Australia/New Zealand	Is There Anything Beyond Reduction of Immunosuppression?	Face Transplantation: Experimental Data	The Donor Perspective: Motives, Potential Benefits and Risks for Organ Vendors	2. Shimon Efrat (Tel Aviv, Israel)	Robotic Donor Nephrectomy	Graft Monitoring and Infection Prophylaxis Guidelines	The IMPAKT Study: Improving Indigenous Patients' Access to Kidney Transplantation	Treatment Controversies	Four Case Studies for Discussion
	Alberton Sanchez-Fueyo (Barcelona, Spain)	Michael Fink (Melbourne, Australia)	Dirk Kuypers (Leuven, Belgium)	Maria Siemionow (Cleveland, USA)	Anwar Naqvi (Karachi, Pakistan)	1. Ed Stanely (Melbourne, Australia)	Raja Kandaswamy (Minneapolis, USA)	Vivekanand Jha (Chandigarh, India)	Alan Cass (Sydney, Australia)	Emma Duncan (Brisbane, Australia)
0800	Discussion	Discussion	Discussion	Face Transplantation - Clinical Data	Discussion	Xenotransplantation	Discussion	Panel Discussion	Discussion	Discussion
				Jean-Michel Dubernard (Lyon, France)		1. Anthony d'Apice (Melbourne, Australia)		Yves Vanrenterghem, Henrik Ekberg, Vivekanand Jha
						2. David Cooper (Pittsburgh, USA)
0830 - 1000	Plenary Session 3 PL03 Bayside Auditorium B
	Stem Cells as a Source of Tissue Replacement and Repair
	Chairs: Megan Sykes, John Horvath
0830	Anthony Atala (Winston-Salem, USA)
	Regenerative Medicine – Is it the Future of Organ Replacement?
0915	Shimon Efrat (Tel Aviv, Israel)
	Preclinical and Clinical Studies of Organ-Specific Stem Cells
1000 - 1200	President's Plenary Bayside Auditorium B
	Chairs: Nicholas Tilney, Kathryn Wood
	WHO Guiding Principles
	Luc Noël
	Organ Donation and Transplantation in China
	Huang Jiefu
	Investigator Awards
	Fellowship and Medawar Prize
	Presidential Address
	Nicholas Tilney
1230 - 1330	Lunch
1200 - 1300	Poster Session 3
1200 - 1300	Mini-Oral Session 17 WMO17 Hall 6 Presentation Booth 1	Mini-Oral Session 18 WMO18 Hall 6 Presentation Booth 2	Mini-Oral Session 19 WMO19 Hall 6 Presentation Booth 3	Mini-Oral Session 20 WMO20 Hall 6 Presentation Booth 4	Mini-Oral Session 21 WMO21 Hall 6 Presentation Booth 5	Mini-Oral Session 22 WMO22 Hall 6 Presentation Booth 6	Mini-Oral Session 23 WMO23 Hall 6 Presentation Booth 7	Mini-Oral Session 24 WMO24 Hall 6 Presentation Booth 8
	Renal 5: ABOi/Highly Sensitised	Immunosuppression 3: Tacrolimus, Sirolimus, Everolimus	Renal Pathology	Immunobiology 3: Immunomodulation 1	Liver 2: Basic Sciences	Paediatrics	Xenotransplantation	Intestinal Transplantation
	Chairs: Au Pen Chen, Solomon Cohney	Chairs: Nicholas Cross, Terence Kee	Chairs: Nicky Isbel, Chul Woo Yang	Chairs: Carla Baan, Shounan Yi	Chairs: Nick Shackel, Winita Hardikar	Chairs: Sean Kennedy, Jeffrey Fletcher	Chairs: Takaaki Kobayashi, Gilles Blancho	Chairs: Jon Odorico
1200	The Use Of Flow Cytometry To Monitor Antibody Levels In Abo Incompatible Kidney Transplantation.	Pharmacokinetics (Pk) Of Tacrolimus For A Once Daily Prolonged Release Formulation (Advagraf®) Versus Twice-Daily (Prograf®) In De Novo Kidney Transplant Recipients In A Phase Iii Multicentre Study	Pitfalls In The Diagnosis Of Chronic Antibody Mediated Rejection: Loss Of Peritubular Capillaries, Wide Spectrum, And Transient Nature Of C4D Deposition	Expression Of Insulin In The Livers Of Prediabetic Non Obese Diabetic Mice May Reduce The Development Of Type I Diabetes	Significant Decrease Of Plasma Adamts13 Activity During Adverse Events After Liver Transplantation	In Vitro Assessment Of Alloreactivity In Living Related Liver Transplantation.	Xenotransplantation Of Microencapsulated Insulin-Producing Pig Cells	Experimental Small Bowel Preservation Using Pacap-38 Containing University Of Wisconsin Solution
	Nithya Krishnan	Nasrullah Undre	A. Bernard Collins	Binhai Ren	Eiji Okano	Udeme Ekong	Jayne Foster	Dora Reglodi
1205	Impact Of Anti-Abo Blood-Type Antibodies On Acute Antibody-Mediated Rejection In Abo-Incompatible Kidney Transplantation	A Post-Hoc Analysis Of The Safety And Efficacy Of Tacrolimus (Prograf) Versus A 'Generic Formulation' Of Tacrolimus (Tenacrine) As Primary Immunosuppressive Therapy In Lrd And Cad, Adults And Pediatric Renal Transplant Recipients.	Effects Of Mtor-Inhibition On Hypoxic Adaptation By Hif – Preferential Influence On Erythropietin Regulation	Efficient And Long-Lasting Aav8 Vector –Mediated Transgene Expression In Heart Transplants	Potential Risk Of Platelet Transfusion In View Of Significant Decrease Ofadamts13 Activity After Liver Transplantation	Comparison Of De Novo Cya-Everolimus With Cya-Aza And Cya-Mmf In Pediatric Heart Transplant Patients	Prolonged Survival Of Microencapsulated Neonatal Porcine Islet Xenografts In Immune-Competent Mice Without Anti-Rejection Therapy –In Vitro Co-Culture Wishbone Marrow And Sertoli Cells	Tnf Alpha Inhibitors Reduce The Inflammatory Response To I/R Injury In A Rat Intestinal Transplant Model
	Daisuke Toki	ALBERTO HOLM	Michael Wiesener	Janne Jokinen	Saiho Ko	Stephan Schubert	Hossein Arefanian	Andreas Pascher
1210	Blood Group B Primary And Regraft Candidates Are Transplanted With A2/A2Bkidneys At The Same Rate Since A Isoagglutinins Remain Low	Prospective Randomized Study Of Pharmacogenetic Adaptation Of Tacrolimus Treatment After Renal Transplantation.	Effects Of Pituitary Adenylate Cyclase Activating Polypeptide (Pacap) On The Survival, Morphology, Apoptotic Signaling And Oxidative Stress In Rats Subjected To Renal Ischemia/Reperfusion	Cyclin Kinase Inhibitor P21-Mediated Immune-Tolerance: Direct And Indirect Evidence	Does C4D Complement Split Product Expression In Perioperative Liver Allograft Biopsies Really Prove The Activation Of Recipient’S Immunological System?	Post Transplant Lymph Proliferative Disease (Ptld) In Pediatric Heart Transplantation. Interplay Between Primary Epstein-Barr Virus Infection And Immunosuppression.	Transparent Immunoisolative Microcontainers For Xenotransplantation	Experimental Small Bowel Transplantation From Non Heart Beating Donors (Nhbd): A Large Animal Study
	John L Smith	Eric Thervet	Dora Reglodi	Mandeep Mehra	Magdalena Durlik	Stephan Schubert	Barjor Gimi	Mario Alessiani
1215	Double Filtration Plasmapheresis Facilitates Hla Antibody Incompatible Renal Transplantation, But Is Less Effective During Antibody Resynthesis Post-Transplantation.	Three-Year Experience With Tacrolimus Once-Daily Prolonged Release In Kidney, Liver And Heart Recipients	483 Donor Kidney Biopsies: Predonation Risk Factors And Histology	Reduced Development Of Transplant Arteriosclerosis In Adenosine Diphosphate (Adp) Receptor P2Y12-Deficient Recipient Mice	Alloantibody Mediated Rejection (Amr) In Liver Grafts: C4D Staining And Donor Specific A Antibodies (Dsa) In Three P Positive Crossmatch Recipients	Prognostic Value Of Computerized Quantification Of Liver Fibrosis In Children With Biliary Atresia Before Liver Transplantation	Measuring Oxygen Consumption As A Predictor Of Islet Cell Potency Prior To Transplantation	Tolerance And Sustained Peripheral Chimerism Following Mhc Matched And Class I Mismatched Intestinal Transplantation In Mgh Miniature Swine
	Rob Higgins	Johannes P Van Hooff	Lauri Kyllönen	Yuji Matsumoto	Tomasz Kozlowski	Lars Pape	Andrew Pepper	Yoshinori Ishikawa
1220	Abo-Incompatible Renal Transplantation Without Splenectomy Or Rituximab –Excellent Renal Function And Graft Histology	Preliminary Two-Year Efficacy Results From A Randomized, Open-Label, Comparative Study Of Two Different Sirolimus (Srl) Regimens Versus A Tacrolimus (Tac) +Mycophenolate Regimen (Mmf) In De Novo Renal Allograft Recipients	Donor Biopsy Histology And Results Of 833 Deceased Donor Kidney Transplantations	Thrombospondin-1 (Tsp-1) Mediates The Anti-Angiogenic And Immunomodulatory Effects Of Rapamycin On Pancreatic Islet Endothelial Cells: Relevance For Islet Transplantation	Mouse Mammary Tumour Virus - Like Virus (Mmtv-Lv) Is Present In Livers Of A Wide Range Of Hepatic Conditions	Ebv Surveillance By Plasma Rt-Pcr After Paediatric Liver Transplantation	Adult Porcine Sertoli Cells Suppress The Xenograft Responses To Porcine Islets In Rats More Effectively Than Neonatal Sertoli Cells	Rescue Of Intestinal Function In Patients Referred For Multivisceral And Intestinal Transplantation
	Shaun Flint	Stuart Flechner	Lauri Kyllönen	Vincenzo Cantaluppi	William Rawlinson	Winita Hardikar	David White	Eddie Island
1225	Results Of A Randomized Prospective Study Of Induction Therapy With Daclizumab Versus Thymoglobulin Among Crossmatch Positive Renal Transplant Recipients	Minimization Of Immunosuppressive Drug Therapy At 6 Months After Renal Transplantation: Everolimus Or Cyclosporin Superior To Mycophenolate Sodium.	Heparin Binding Epidermal Growth Factor (Hb-Egf) Is Detrimental In Ischemia/Reperfusion Injury (Iri)	Immune Cell Activation Comparing Three Induction Agents (Alemtuzumab, Thymoglobulin And Basiliximab) With Tacrolimus, Mycophenolate Moretil And A Rapid Steroid Withdrawal In Renal Transplantation	Are Post Reperfusion Subcapsular Wedge Biopsies Useful In Predicting Graft Initial Poor Function After Liver Transplantation?	Living-Related Donor Liver Transplantation For Children With Fulminant Hepatic Failure In Israel	The Westran Pig: An Ideal & Safe Donor Source For Xenotransplantation.	Transplantation Of The Stomach – Clinic Pathological Outcomes Review Of The Gastric Allograft Included In Multivisceral Graft
	Jayme Locke	Ineke JM ten Berge	Harry Van Goor	John Holman	Beyhan Demirhan	Yaron Avitzur	Denbigh Simond	Tomoaki Kato
1230	The Never-Ending Altruistic Donor	Sirolimus Is Associated With Worsen Outcome Compared To  Mycophenolate Mofetilin High Immunologic Risk Renal Transplant Recipients Receiving Tacrolimus Combined  With Atg Induction	Association Between De Novo Donor Specific Hla Antibody, C4D Staining In Renal Graft Biopsy, And Graft Outcome	Influence Of Medical Immunosuppression On Cmv-Specific T-Cell Therapy: Conclusions From In Vitro- And Clinical Observations	Graft Preconditioning With Low-Dose Tacrolimus (Fk506) And Nitric Oxide Inhibitor (Agh)  Reduces Ischemia/Reperfusion Injury After Liver Transplantation In The Rat	Development Of Allergic Diseases Following Orthotopic Liver Transplantation In Children	Analysis Of Transmembrane Form Of Complement Regulatory Proteins Should Be Expressed In Transgenic Pigs To Avoid Perv Infection	Recovery From Liver Dysfunction After Adult Isolated Intestinal Transplantation Without Liver Grafting
	Michael Rees	Magdalena Durlik	Brian Hardy	Gordon Brestrich	Norbert Huser	Winita Hardikar	Shuji Miyagawa	Chiara Zanfi
1235	Donor & Recipient Attitudes Towards Altruistic Unbalanced Paired Kidney Exchange And Its Potential Impact On Live Donor Transplantation	Influences Of Immunosuppressive Agents On Graft Survival: The Impact Of De Novo Cni Minimization Combined With Sirolimus	Comparison Of Biopsy And Clinical Score Systems To Predict Outcome Of Extended Criteria Kidney Donors	How Does The Kidney Fight Back? The Role Of Serpins In Renal Allograft Rejection	Amanitine Intoxication In A Porcine Model: When Transplant, When Wait For Regeneration?	Prevalence Of Cytomegalo- And Adenovirus-Specific T-Cells In Correlation To Virus-Dna And -Serology Before Pediatric Renal Transplantation	Knock Down Of Treg Function Gene Expression By Sirna Results In Reduced Suppressive Potency Of Human Treg On Porcine Xenogeneic Effector T Cells Invitro	Bacterial Translocation In Adult Intestinal And Multivisceral Transplantation
	Lloyd Ratner	Meng-Kun Tsai	Alessandro Faenza	Kirstin Heutinck	Martin Schenk	Thurid Ahlenstiel	Lei Sun	Chiara Zanfi
1240	Il-6R Blockade In Experimental Autoimmune Nephritis Reduces Proteinuria And Is Associated With Tregs In The Draining Lymph-Node	Delayed Introduction Of A Calcineurin-Inhibitor (Cni)-Free, Sirolimus (Srl)-Based Immunosuppression In Renal Transplantation Is Safe. Preliminary Results Of The Randomised, Multicenter Smart Trial.	Chronic Transplant Glomerulopathy – Clinical And Pathological Correlates	Rapamycin Induces Autophagy In Islets: Relevance For Islets Transplantation		Role Of Hla Matching In Organ Allocation: Balance Between Graft Survival And Sensitization In Pediatric Kidney Transplants	Intra- And Extracellular Remodelling Effectively Prevent Human Cd8+ Ctl-Mediated Xenocytotoxicity By Co Expression Of Membrane-Bound Human Fasl And Pig C-Flipl In Pig Endothelial Cells
	Geoff Zhang	Karl-Walter Jauch	Magdalena Durlik	Masahiro Tanemura		Peter Stock	Masahiro Tanemura
1245	Successful Transplantation Of Patients With Low Level Donor Hla Specific Antibody Without Desensitization Treatment	Results Of A Calcineurin-Inhibitor-Free Immunosuppressive Protocol In Renal-Transplant Recipients Of Expanded Criteria Deceased Donors (Ecd). 5-Yearanalysis.		Accelerated Rat Cardiac Allograft Failure Is Prevented By Anti-Icos Immunotherapy: Implications For Control Of Chronic Rejection		Hepatic Artery Thrombosis After Pediatric Liver Transplantation:  Identification And Characterization Of A Novel Risk Factor	In Vivo Controlling Of Cellular Response To Pig Islet Xenografts By Adenovirus-Mediated Expression Of Either Membrane-Bound Human Fasl Or Human Decoy Fas
	Mary Leffell	Luis Santiago Re		Lei Guo		Jayme Locke	Masahiro Tanemura
1250	Treatment And Prognosis Of Late Onset Humoral Rejection In Comparison With Early Onset Humoral Rejection In Kidney Transplants.	Safety And Efficacy Of Everolimus Vs Mycophenolate Mofetyl With Csa In Denovo Live Related Renal Transplantation				Long-Term Outcome Of Renal Transplantation In Children Below 12 Kg At Transplantation	Comparison Of Whole Blood Coagulation Assessment Using Thromboelastometry (Rotem®) Between Human And Cynomolgus Monkeys
	Duck Jong Han	R K Sharma				Ulla Berg	Massimo Boldrin
1255		Post-Operative Tissue Regeneration In Renal Transplantation: Comparable Outcome With Everolimus Or Mmf				The Efficacy And Safety Of Valganciclovir Vs. Oral Ganciclovir In The Prevention Of Cmv Infection In Children After Solid Organ Transplantation	Profiles Of Glycoantigens Of The Cells From ƒ¿-1,3Gt Knockout Pig
		Raimund Margreiter				Yaron Avitzur	Shuji Miyagawa
1200 - 1300	Tolerance Interest Group Parkside G07
	Astellas Sponsored Symposium
1200 - 1330	Long-Term Outcomes Post-Transplantation: Are We Making Progress? Bayside Grand Hall
	Chairs: Stephen Munn, Han Duck Jong
1200	Evolving trends and unmet needs in post-transplant care
	Bruce Kaplan (USA)
1215	Liver transplantation: improving long-term outcomes
	Geoff McCaughan (Australia)
1245	Kidney transplantation: improving long-term outcomes
	Henrik Ekberg (Sweden)
1315	Panel Discussion
1330 - 1500	State-of-the-Art Symposium Concurrent Session 21 STA21 Bayside Auditorium B	State-of-the-Art Symposium Concurrent Session 22 STA22 Parkside Auditorium	State-of-the-Art Symposium Concurrent Session 23 STA23 Bayside Auditorium A	State-of-the-Art Symposium Concurrent Session 24 STA24 Bayside 102	State-of-the-Art Symposium Concurrent Session 25 STA25 Parkside Ballroom B	State-of-the-Art Symposium Concurrent Session 26 STA26 Parkside 110A	State-of-the-Art Symposium Concurrent Session 27 STA27 Bayside 204 A&B	State-of-the-Art Symposium Concurrent Session 28 STA28 Bayside Gallery	State-of-the-Art Symposium Concurrent Session 29 STA29 Bayside 103	State-of-the-Art Symposium Concurrent Session 30 STA30 Parkside 110B
	Premature Vascular Death with a Functioning Graft	Liver Transplant - Live Donation	Immunosuppressive Protocols to Improve Long Term Outcomes	New Technology in Heart And Lung Transplantation	Role Of Endothelium And Angiogenesis In Graft Outcomes	Long Term Outcomes in Pancreas Transplantation	Improving Hospital Performance In Deceased Donor Organ Donation	Late Onset Infectious Diseases Following Solid Organ and Haematopoietic Transplantation	Tissue Repair Using Mesenchymal, Haematopoietic and Endothelial Progenitor Cells	Genetic Modifications That Improve Xenograft Survival
	Chairs: Bengt Fellstrom, Marcelo Cantarovich	Chairs: Roy Calne, Chung Mau Lo	Chairs: Yves Vanrenterghem, Andrew Bradley	Chairs: Hans Lehmkuhl, Gregory Snell	Chairs: Ian McKenzie, Joren Madsen	Chairs: Stephen Bartlett, Rainer Gruessner	Chairs: Hans Sollinger, Gerry O'Callaghan	Chairs: John Pirsch, Anthony Monaco	Chairs: Shimon Efrat, Derek Hart	Chairs: Mauro Sandrin, Emanuele Cozzi
1330	Impact of Vascular Morbidity and Mortality on Patient Outcomes	Are the Outcomes Good Enough for Donor and Recipient?	Meaningful Endpoints for the Future	New Generation VAD's	How Endothelium Regulates T Cell Activation in the Organ	Management of Surgical Complications of Pancreas Transplantation	Experience with the US Collaborative Program	HBV, HCV Infection From Reactivation and Continuing Infection Following Non-Liver Transplantation	Preclinical and Clinical Studies of Mesenchymal Stem Cells for Myocardial Repair	Outcomes for Gal KO pigs for Cardiac Transplantation
	Hallvard Holdaas (Oslo, Norway)	Robert Merion (Ann Arbor, USA)	Marc Cavaille-Coll (Washington DC, USA)	Robert Higgins (Chicago, USA)	Andrew Lichtman (Boston, USA)	Rainer Gruessner (Tucson, USA)	Anthony D'Alessandro (Madison, USA)	Geoffrey McCaughan (Sydney, Australia)	Silviu Itescu (Melbourne, Australia)	David Cooper (Pittsburgh, USA)
1400	What Are the Cardiac Risk Factors in Renal Transplantation and How Should We Treat Them?	HCV Infection and Live Donation	Decision Pathways for Tailoring Immunosuppression to Individual Patients	Artificial Lungs - The NOVA Lung	cAMP Dependent Mechanisms of Endothelial Cell Permeability	Immunosuppression - Outcomes of Novel Protocols	The Role of the Intensivist in Organ Donation	Polyomavirus Infection and Emerging Treatments Following Solid Organ and Haematopoietic Transplantation	Use of Haematopoietic Stem Cells and Endothelial Progenitor Cells for Myocardial Repair	Role of Complement and Thromboregulaton in Xenotransplantation
	Helen Pilmore (Auckland, New Zealand)	Robert Brown (New York, USA)	Douglas Norman (Portland, USA)	John Dark (Newcastle, UK)	Tanya Mayadas (Boston, USA)	David Sutherland (Minneapolis, USA)	Cameron Guest (Toronto, Canada)	Daniel Brennan (St. Louis, USA)	Peter Macdonald (Sydney, Australia)	Peter Cowan (Melbourne, Australia)
1430	PTDM - Diagnosis, Monitoring and Management	HCC - Are the Results Worse Than for Cadaveric Donation?	What is the Evidence for Improving Long Term Outcomes?	Organ Transportation - Transmedics System	Role of Thrombin in Allograft Vasculopathy	Does Pancreas Transplantation Improve Secondary Complications of Diabetes?	Donor Action	Community Acquired Respiratory Viruses and Fungal Infections in Lung Transplantation	Mesenchymal Stem Cells as a Novel Immune Suppressive Agent	Outcomes for Gal KO Pigs for Renal Transplantation
	Steven Chadban (Sydney, Australia)	Chung Mau Lo (Hong Kong)	Yves Vanrenterghem (Leuven, Belgium)	John Wallwork (Cambridge, UK)	Anthony Dorling (London, UK)	Brian Nankivell (Sydney, Australia)	Bernard Cohen (Oegstgeest, The Netherlands)	Michael Ison (Chicago, USA)	Katarina LeBlanc (Stockholm, Sweden)	Kazuhiko Yamada (Boston, USA)
1500 - 1530	Afternoon Tea
1500 - 1530	Surgical Video Session WSV01 Hall 6 Presentation Booth 1
	More Surgical Videos
	Chairs: Vincent Lam, Brendan Ryan
1500	Renal Transplant Biopsies:  Introducing The Glide Path Approach And Skewer Technique For Safe & Effective Biopsy Practice
	Arunthathi Oormila Mahendran
1510	Our Technique Of Obtaining Cuff Of Inferior Vena Cava During Right Sided Retroperitoneoscopic Donor Nephrectomy
	Pranjal Modi
1520	Live Donor Kidney Transplantation Following Extracoporeal Repair Of Renal Arteryaneurysm
	Fabio Vistoli
1530 - 1700	Concurrent Oral Session 41 WO41 Bayside Auditorium B	Concurrent Oral Session 42 WO42 Parkside Auditorium	Concurrent Oral Session 43 WO43 Bayside Auditorium A	Concurrent Oral Session 44 WO44 Bayside Room 102	Concurrent Oral Session 45 WO45 Parkside Ballroom B	Concurrent Oral Session 46 WO46 Parkside 110A	Concurrent Oral Session 47 WO47 Bayside Room 204 A & B	Concurrent Oral Session 48 WO48 Bayside Gallery	Concurrent Oral Session 49 WO49 Bayside Room 103	Concurrent Oral Session 50 WO50 Parkside 110B
	Cardiovascular and Metabolic Disease in Renal Transplantation	Liver Malignancy	Renal Long-term Immunosuppression	CMV and Other Viral Diseases	Cytokines	Chimerism	Acute Rejection and HLA	Transplant Surgery Videos	Xenotransplantation - Pig-to-Primate/Immune Responses	Maintenance Immunosuppression and Long-Term Complications
	Chairs: John Kanellis, E. Steve Woodle	Chairs: Satoru Todo, Stefan Hubscher	Chairs: Wolfgang Arns, Han Duck Jong	Chairs: James Mackie, Hiroshi Tagaki	Chairs: Foo Liew, Alexandra Sharland	Chairs: Martin Gasser, Frank Ierino	Chairs: Robert Steiner, Graeme Russ	Chairs: Howard Lau, Justin Roake	Chairs: Joseph Leventhal, Kazuhiko Yamada	Chairs: Philip Li, Felix Cantarovich
1530	Reduction In Cardiovascular Death Rates After Kidney Transplantation In Australia And New Zealand	Decreasing Disparity In Liver Transplantation Among White And Asian Patients With Hepatocellular Carcinoma, California, 1998−2005	Long-Term Safety Of Belatacept: 6 Year Results Of A Phase Ii Study	Human Cytomegalovirus Antiviral Resistance In Immunocompromised Transplant Recipients	Absence Of Neutrophil-Mediated Renal Dysfunction And Tubular Cell Apoptosis Following Renal Ischemia/Reperfusion In Cxcr2-/- Mice	An Irradiation-Free Protocol For Mixed Chimerism And Tolerance Through Treg-Therapy	Successful Transplantation Of Donor Specific Antibody Positive, Crossmatch Negative (Ahg/Fcxm) Renal Allograft Recipients	Minimally Invasive Kidney Transplantation (Mikt) -A 7-9 Cm Incision Is Sufficient	Average Survival Greater Than 50 Days With Evidence For Baboon Thymopoiesis In Porcine Thymus In Baboon Recipients Of Life-Supporting Galt-Ko Pig Thymokidneys	Results From The Pan-European-Htx Trial
	Helen Pilmore	Michael Daily	Ferdinand Muehlbacher	Jenna Iwasenko	Robert Fairchild	Nina Pilat	Ronald Kerman	Per Pfeffer	Kazuhiko Yamada	Bruno Meiser
1540	Metabolic Syndrome And Cardiovascular Disease Risk In Renal Transplant Recipients In The Alert Trial: Effects Of Statin Treatment	Does The Type Of Pre-Transplant Ablative Therapy Affect Survival After Liver Transplantation For Patients With Hepatocellular Carcinoma (Hcc)?	African-American Kidney Transplant Recipients Undergoing Early Corticosteroid Withdrawal Long Term (5 Year) Results Similar To Non-African Americans	Investigations Into The Pathogenesis Of Cytomegalovirus-Induced Transplant-Arteriosclerosis Using A Humanized Mouse Model	Il-4 Treatment Of The Liver Donor Induces Alternatively-Activated (Type 2)Macrophages And Converts Liver Transplant Rejection To Acceptance	Influence Of Chimerism On Tolerance After Combined Human Kidney And Hematopoietic Cell Transplantation	The Presence Of An Antibody Component In Acute Cellular Rejection Decreases Renal Allograft Survival	Retroperitoneal Placement Of Pancreas Graft With Portal-Enteric Drainage	Functional Analyses Of Cd55/Hho1 Transgenic Pigs In An Ex Vivo Perfusion Model	Decrease Of Major Cardiac Events And Hospitalizations In De Novo Heart Transplant Recipients Receiving Everolimus: Results From A 12-Month,Multicenter, Randomized Trial Comparing Everolimus With Mmf
	Inga Soveri	Diane Steffick	E. Steve Woodle	Stephan Ensminger	Chuanmin Wang	Stephan Busque	Matthew Everly	Fabio Vistoli	Wolf Ramackers	Elke Lehmkuhl
1550	Antihypertensive Therapy For Kidney Transplant Recipients: A Systematic Review And Meta-Analysis	Ablation Of Hepatocellular Carcinoma As A Bridge To Liver Transplant Prolongs Wait List Eligibility	Cni Sparing With Mycophenolate Mofetil In De Novo Renal Transplantation: 3-Yearresults From The Symphony Study	A Prospective Study Of Viral Genetic Polymorphisms In Cmv Glycoprotein B And Their Association With Clinical And Virologic Outcomes In Patients With Cmv Disease: Results From The Victor Study	Il-18 Deficiency In Recipients Induced Early Rejection Of Mhc Class Ii-Disparate Cardiac Allograft In Mice	Tolerance Induction In A Large-Animal Model Using Total Lymphoid Irradiation And Intrathymic Bone Marrow	Serial Monitoring Of Anti Hla-Antibodies In Living Related Renal Allograft Recipients In Early Post-Transplant Period And Correlation With Protocol Histology	Technique For Restored Kidney Transplantation (Rkt) Using Kidneys Removed With Small Renal Tumours.	Igvh Genes Encoding Xenoantibodies To Gal Tko Xenoantigens In Rhesus Monkeys Are Restricted	Chronic Kidney Disease In Uk Heart Transplant Recipients
	Nicholas Cross	Les Lilly	Henrik Ekberg	Oriol Manuel	Hung-Ta Ko	Peter Horton	Mukut Minz	David Nicol	Mary Kearns-Jonker	Rachel Johnson
1600	Genetics Of New-Onset Post Transplant Diabetes Mellitus (Noptdm)	Living Donor Liver Transplantation For Patients With Hepatocellular Carcinoma –Effects Of Pre-Transplant Treatments	Stable Trough Levels But Significant Reduction Of The Area Under The Curve Of Tacrolimus In Renal Transplanted Patients Converted From Associated Mycophenolate Mofetil To Equimolar Doses Of Enteric-Coated Mycophenolate Sodium	Demonstration Of Hhv-6 Antigens In Biopsies Of Kidney Transplant Recipients With Cmv Infection	Lymphocyte, But Not Parenchyma-Derived Cxcl10 Is Critical In Liver Innate Immune Response Against Ischemia And Reperfusion Injury	Induction Of Alloreactive Cd4 Tolerance By Cross-Presentation Of Donor Mhc Molecules By Recipient Apc'	Antibody-Mediated Rejection In Renal Allograft Recipients Treated With Alemtuzumab Induction	Our Technique Of Obtaining Cuff Of Inferior Vena Cava During Right Sided Retroperitoneoscopic Donor Nephrectomy	High Titer Pre-Transplant Anti-Pig Igm In Primates Are Not Necessarily Associated With Early Porcine Xenograft Failure	Long-Term Immunosuppression With Anti-Cd25 Monoclonal Antibodies In Heart Transplant Patients
	Ian Hutchinson	Yasutsugu Takada	Josep M. Puig	Ilkka Helanterä	Jerzy Kupiec-Weglinski	Josef Kurtz	John Pirsch	Pranjal Modi	Federica Besenzon	Marcelo Cantarovich
1610	Late Steroid Withdrawal And Cardiovascular Events In Kidney Transplant Recipients	Elevated Preoperative Neutrophil To Lymphocyte Ratio Predicts Outcome Inpatients With Hcc After Liver Transplantation.	Ten-Year Follow-Up Of A Multicentre Kidney Transplant Study Disclose Higher Graft Survival And Better Renal Function In Tacrolimus Therapy	Oral Valganciclovir And Intravenous Ganciclovir Results In Comparable Long-Term Outcomes In Transplant Recipients With Cmv Disease: The Victor Study	Il-1Beta-Driven St2 Expression Promotes Maturation Resistance Inrapamycin-Conditioned Dendritic Cells	Requirement For Mhc Class I And Ii Expression On Host Dendritic Cells To Tolerize Alloreactive Cd8 Cells During Induction Of Mixed Chimerism	Non-Hla Antibodies Reactive With Endothelial Cells Could Be Involved In Early Loss Of Renal Allografts	Hand-Assisted Laparoscopic Living Donor Nephrectomy And Distal Pancreatectomy For Simultaneous Pancreas And Kidney Transplant	B Cell Proliferation After Á-Gal Exposure Requires The Presence Of Activated T Helper Cells	Late Onset Antibody-Mediated Rejection And Endothelial Localisation Of Vascular Endothelial Growth Factor Are Associated With Development Of Cardiac Allograft Vasculopathy
	Miha Arnol	Karim J Halazun	Jose María Morales	Anders Åsberg	Angus Thomson	Joshua Mollov	Carla Regina Da Silva Correa R Ronda	Naotake AKUTSU	Teodora Kandeva	Julianne Bayliss
1620	Cardiovascular Events And Mortality In Renal Transplant Recipients: Early Corticosteroid Cessation Regimens Versus Chronic Corticosteroid Therapy	The Impact Of Meld On Patient Survival And Disease Free Survival In Patients Receiving Liver Transplant For Hepatocellular Carcinoma	A Three Year Follow-Up Study Of Stable Kidney Transplant Recipients Converted From Twice Daily Prograf® To Once Daily Extended Release Tacrolimus	Donor-Derived Disease Transmission Events In The United States 2006 - 2008:  A Report From The Optn/Unos Diseases Transmission Advisory Group (Dtag)	Il-21 Alters Immune Regulation And Promotes Th17 In Alloresponse	Chimeric Tolerance Induced By Total Lymphoid Irradiation And Donor Specific Bone Marrow Infusion In Dla-Dp Matched Dogs.	Risk Factors And Associations With Alloantibodies In Transplant Glomerulopathy	Hand-Assisted Scopic Living Donor Nephrectomy: A Single Centre Experience During The Minimally Invasive Era	In Vitro Investigation Of Human Cellular And Humoral Responses To Cells From Genetically-Modified Pigs	Microarray  Analysis Shows That  Neuropilin2, Esdn, Vascular Endothelial Growth Factor Receptors 1 And 2 (Vegfr1 And 2) Are  Differentially Expressed In Proliferative Coronary Lesions From Atherosclerotic And Transplant Vasculopathy Human Arteries.
	E. Steve Woodle	Dilip Moonka	Roy First	Michael Ison	Maria Koulmanda	Wayne Hawthorne	Hooi Sian Eng	Per Pfeffer	Mohamed Ezzelarab	E. Rene Rodriguez
1630	New Onset Metabolic Syndrome After Renal Transplantation: Effects Of Maintenance Steroid Therapy And Diabetes	Positive Impact On Survival Of Meld Prioritization For Patients With Cirrhosis And Small Unresectable Hepatocellular Hepatocarcinoma Compared With Living Donor Liver Transplantation	Efficacy, Tolerability And Safety Of Mycophenolate Mofetil (Cellcept) +Sirolimus (Rapamune) As Maintenance Therapy After Calcineurin Inhibitor Withdrawal In Lrd And Cad, Adults And Pediatric Renal Transplant Recipients. (Experience With 405 Patients).	No Exclusion Of Hhv-8 Infected Donors And Recipients For Kidney Transplantation: A French Prospective National Cohort	Interleukin-13 Signaling Through The Interleukin-13-Receptor-Alpha2 Is Involved In The Induction Of Transforming Growth Factor-Beta1 Production And Organ Fibrosis	Donor Bone Chimerism And Is Sufficient To Promote Allograft Tolerance After Heterotopic Hind Limb Transplantation	Evaluation Of Intra-Graft B-Cell Subsets In Renal Allograft Rejection	Non-Related Living Donor Horseshoe Kidney Transplantation	Human Cd47 On Porcine Antigen Presenting Cells Have A Possibility Of Preventing T Cell-Mediated Xenograft Rejection Through Inhibitory Signaling To Sirp Alpha	Immunofluorescence Detection Of Complement Activation Products C4D And C3Dcorrelates With Cardiac Allograft Dysfunction And Donor Specific Antibodies Inhuman Heart Transplants.
	E. Steve Woodle	Alejandra Villamil	ALBERTO HOLM	Camille Frances	Stefan Fichtner-Feigl	Suzanne Illdstad	Maarten Naesens	Fabio Vistoli	Kentaro Ide	Carmela D. Tan
1640	The Effects Of Rosuvastatin On Insulin Sensitivity And Secretion In Non-Diabetic Renal Transplant Recipients	Incidental Hepatocellular Carcinoma After Liver Transplantation: Population Characteristics And Outcomes	Interleukin-2 Receptor Antagonist Reduces Rejection Rates And Graft Loss In Live-Donor Kidney Transplant Recipients	Long Term Experience With The Use Of Kidneys From Hcv Positive Donors Into Hcv Positive Recipients: A Spanish Collaborative Study	Interleukin-21 Receptor On B-Lymphocytes Is Unregulated In Highly Sensitized Renal Transplant Recipients: A Potential Target For Desensitization.	Long-Term Allograft Survival In Unmanipulated Hosts By Post-Transplant Infusion Of Donor-Specific Regulatory T Cells And Rapamycin.	Probabilistic Modeling Of Cmv Infection In Renal Transplantation	Control Of Intraoprative Bleeding During Hand-Assisted Laparoscopic Donor Nephrectomy	Rna Microarrays Of Macrophages From Rejecting Islet Grafts Identify Unique Gene Expression And Pathway Activation Patterns Following Xenograft Rejection.	Is Complement Activation Without Allograft Dysfunction Indicative Of" Accommodation” In Heart Transplant Recipients?
	Adnan Sharif	Dilip Moonka	Wai Lim	Beatriz Dominguez-Gil	Reza Tavana	Giorgio Raimondi	Paul Keown	Zaki Anas Zarka	JingJing Wu	E. Rene Rodriguez
1650		The Place Of Liver Transplantation In The Treatment Of Hepatic Epitheloid Haemangioendothelioma :Report Of The European Liver Transplant Registry (Eltr)	Final Results Of The Spare The Nephron Trial (Cni Withdrawal Trial)	Multivariate Analysis Of 81 Liver Transplants (Lt) From Htlv I/Ii Donors - Unos Registry Data		Donor Cell Infusion Without Immunosuppression As A Novel Therapy For Induction Of Donor-Specific Tolerance In Islet Cell Transplantation		Hand Transplantation: Video Description Of The Procedure And  Surgical Technique For Donor Limb Harvest	Human Immune Responses To Islet Xenografts	Role Of Lipids In The Development Of Stenotic Microvasculopathy After Heart Transplantation
		Jan Lerut	Thomas C. Pearson	Michael Marvin		Xunrong Luo		Bardia Amirlak	Susan Safley	Nicola Hiemann
	Novartis Sponsored Symposium
1715 - 1815	Focussing On Long-Term Graft Protection In Renal Transplantation Bayside Grand Hall
	Chair: Steve Chadban
1715	Welcome and introduction
	S. Chadban
1720	Is acute rejection the determinant for long-term outcome?
	B. Nashan
1735	BKV nephropathy - the emerging issue in renal transplantation
	H. Hirsch
1750	Death with a functioning graft – NODAT a key risk factor
	S. Chadban
1805	Q & A